Karveland Tablets 12.5mg No. 10×3: Effective Blood Pressure Management
Description:
Karveland tablets contain carvedilol, a non-selective beta-blocker with alpha-blocking and antioxidant properties. It is used for managing high blood pressure (hypertension), ischemic heart disease, and chronic heart failure.
How it Works:
Karveland effectively lowers blood pressure by:
- Blocking alpha-1 receptors: This causes vasodilation (widening of blood vessels), reducing peripheral resistance and lowering blood pressure.
- Blocking beta-1 and beta-2 receptors: This slows the heart rate, reduces the force of heart contractions, and reduces the renin-angiotensin-aldosterone system activity, minimizing fluid retention.
- Antioxidant properties: Carvedilol protects cells from damage caused by free radicals, promoting overall heart health.
Key Benefits:
- Reduces blood pressure: Helps effectively control hypertension.
- Reduces risk of heart attacks and strokes: Protects against cardiovascular events in patients with ischemic heart disease.
- Improves heart function: Improves heart function and quality of life in patients with chronic heart failure.
Dosage and Administration:
The dosage of Karveland is individualized based on your condition and medical history. Consult with your doctor for the appropriate dose and schedule.
Possible Side Effects:
Common side effects include dizziness, headache, fatigue, and constipation. Some individuals may experience more severe side effects, such as bradycardia, hypotension, or bronchospasm.
Important Precautions:
- Heart Failure: May worsen heart failure symptoms during initial dose adjustment.
- Diabetes: May mask symptoms of hypoglycemia.
- Peripheral Vascular Disease: May worsen symptoms.
- Thyrotoxicosis: May mask symptoms.
- Pregnancy and Lactation: Not recommended.
- Interactions: Can interact with other medications.
Always consult with your doctor before taking Karveland or any other medication.
Buy Karveland Tablets 12.5mg No. 10×3:
Find the best price and order online.
Please note: This information is not a substitute for professional medical advice. Always consult with your doctor before making any decisions about your health or treatment.
| INN | CARVEDILOL |
|---|---|
| The code | 24 487 |
| Barcode | 4 810 368 013 033 |
| Dosage | 12.5mg |
| Active substance | Carvedilol |
| Manufacturer | Pharmland SP LLC, Belarus |
| Indications Applications | Arterial hypertension. Essential hypertension (in monotherapy – or in combination with other antihypertensive agents, for example, blockers of "slow" calcium channels or diuretics). Ischemic heart disease (including in patients with unstable angina and painless myocardial ischemia). Chronic heart failure. Treatment of stable and symptomatic mild, moderate and severe chronic heart failure (FC II-IV according to the New York Heart Association, NYHA) of ischemic or non-ischemic origin in combination with hypotensin-converting enzyme (ACE) inhibitors and diuretics, with or without cardiac glycosides (standard therapy), in the absence of contraindications. |
| Contraindications | hypersensitivity to carveland or any component of the drug, acute heart failure, decompensated heart failure (class IV NYHA), requiring intravenous administration of drugs, atrioventricular block II and III degree, severe bradycardia less than 50 beats / min, sick sinus syndrome (incl. h. sinotrial blockade), severe arterial hypotension (systolic blood pressure less than 85 mm Hg. Art.), cardiogenic shock, chronic lung disease with a bronchospastic component, bronchial asthma, clinically pronounced liver damage, pregnancy, lactation, age up to 18 years. |
| Side effects | Central nervous system: dizziness, headaches and weakness, asthenia (including fatigue), especially at the beginning of treatment, rarely – depression, sleep disturbances, paresthesia. Cardiovascular system: bradycardia, orthostatic hypotension, postural hypotension, pronounced decrease in blood pressure, edema (including generalized, peripheral, depending on body position, perineal edema, edema of the lower extremities, hypervolemia, fluid retention), rarely – fainting (in the beginning of treatment), syncopal conditions (including presyncopal), atrioventricular blockade and heart failure during the period of increasing the dose, peripheral circulatory disorders (cold extremities, exacerbation of the "intermittent" claudication syndrome and Raynaud's syndrome), . Respiratory organs: bronchospasm and shortness of breath in predisposed patients, rarely – nasal congestion. Gastrointestinal: dyspeptic disorders (including nausea, abdominal pain, diarrhea, vomiting) rarely – constipation, changes in liver transaminase activity. Hematopoietic system: rarely: thrombocytopenia. Individual cases of leukopenia. Metabolic disorders: weight gain hypercholesterolemia; in patients with pre-existing diabetes mellitus – hyperglycemia or hypoglycemia, decompensation of carbohydrate metabolism. Skin: skin reactions (allergic rash, dermatitis, urticaria and itching). Urinary system: rarely – renal failure and impaired renal function in patients with diffuse vasculitis and / or impaired renal function, dysuria. Organs of vision: blurred vision, decreased lacrimation. Other: pain in the limbs, dry mouth, impotence. |
| Use during pregnancy and lactation | Forbidden to use |
| Age category | 18+ |
| Application Gender | Any |
| Release Form | tablets |
| Main Active Substances | carvedilol |
| Composition Means | Active ingredient: carvedilol – 6.25 mg, 12.5 mg or 25 mg. Excipients: lactose monohydrate, sucrose, povidone K-30, crospovidone, anhydrous colloidal silicon dioxide, magnesium stearate, iron oxide (yellow) E 172 (dosages 12.5 mg and 25 mg), iron oxide (red) E 172 (dosage 25 mg). |
Related products
Cardiovascular Health
